PRL-8-53
chemical compound
≈ 1 min read
Names in other languages
- EnglishPRL-8-53
- EspañolPRL-8-53
- РусскийPRL-8-53
- shPRL-8-53
- СрпскиPRL-8-53
- 中文PRL-8-53
Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.
PRL-8-53 is a nootropic substituted phenethylamine that has been shown to act as a hypermnesic drug in humans; it was first synthesized by medical chemistry professor Nikolaus Hansl at Creighton University in the 1970s as part of his work on amino ethyl meta benzoic acid esters.
Mechanism of action
The exact mechanism of action of PRL-8-53 remains unknown. Doses up to 200 mg/kg are not observed to have stimulant properties, and a dosage of 20 mg/kg does not potentiate the effects of dextroamphetamine in rats. It displays possible cholinergic properties, and potentiates dopamine while partially inhibiting serotonin. PRL-8-53 reverses the catatonic and ptotic effects of reserpine.
Toxicity
PRL-8-53 is relatively non-toxic, with an oral in mice of 860 mg/kg, giving the drug a high therapeutic index. Doses above 8 mg/kg have brief hypotensive effects in canines. High doses depress motor activity in the rat and mouse, with the ED 50 for a 50% reduction in motor activity of mice at 160 mg/kg. PRL-8-53 displays spasmolytic effects.
Synonyms
Methyl 3-(2-(benzylmethylamino)ethyl)benzoate hydrochloride 3-(2-benzylmethylaminoethyl) benzoic acid methyl ester hydrochloride 3-(2-(Methyl(phenylmethyl)amino)ethyl)benzoic acid methyl ester hydrochloride
Text derived from https://en.wikipedia.org/w/index.php?oldid=1345291835 under CC BY-SA 4.0; modifications have been made.